Wallace Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Wallace Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$221K	Hold	450	–	–	0.03%	69
2025 Q4	$261K	Sell	450 -25	-5%	-$14.1K	0.03%	63
2025 Q3	$230K	Buy	+475	New	+$221K	0.03%	69
2025 Q2	–	Sell	-505	Closed	-$251K	–	85
2025 Q1	$251K	Hold	505	–	–	0.03%	63
2024 Q4	$263K	Hold	505	–	–	0.04%	63
2024 Q3	$312K	Sell	505 -25	-5%	-$14.8K	0.04%	65
2024 Q2	$293K	Buy	530 +150	+39%	+$85.9K	0.04%	63
2024 Q1	$221K	Sell	380 -900	-70%	-$505K	0.03%	73
2023 Q4	$679K	Buy	1,280 +30	+2%	+$14.5K	0.1%	47
2023 Q3	$633K	Sell	1,250 -10	-0.8%	-$5.33K	0.1%	50
2023 Q2	$657K	Buy	+1,260	New	+$680K	0.1%	53
2022 Q3	–	Sell	-380	Closed	-$204K	–	73
2022 Q2	$204K	Hold	380	–	–	0.03%	68
2022 Q1	$207K	Sell	380 -38	-9%	-$21.8K	0.03%	66
2021 Q4	$279K	Buy	418 +38	+10%	+$23.7K	0.04%	65
2021 Q3	$217K	Sell	380 -20	-5%	-$11K	0.03%	68
2021 Q2	$202K	Buy	+400	New	+$189K	0.03%	67

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wallace Capital Management's TMO Position: Q1 2026 in Review

Wallace Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 450 shares worth $221K. The position accounts for 0.03% of the portfolio, ranked #69.

Wallace Capital Management first reported a position in TMO in Q2 2021 and has held it in 16 quarters since. The position peaked at $679K in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Wallace Capital Management held 450 shares of Thermo Fisher Scientific worth $221K as of Q1 2026.
Wallace Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.03% of Wallace Capital Management's portfolio in Q1 2026, its #69 holding.
Wallace Capital Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 16 quarters since.
Wallace Capital Management's Thermo Fisher Scientific position peaked at $679K in Q4 2023.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Wallace Capital Management's 13F filing for Q1 2026, filed 15 May 2026.